Similar Articles
1711 Non-viral factors contributing to hepatocellular carcinoma
1712 Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus
1713 Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma
1714 Hepatocellular carcinoma: Clinical study of long-term survival and choice of treatment modalities
1715 Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients
1716 Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma
1717 Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan
1718 Transarterial embolization of metastatic mediastinal hepatocellular carcinoma
1719 Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases
1720 Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA